Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

6.7%

1 terminated/withdrawn out of 15 trials

Success Rate

92.9%

+6.4% vs industry average

Late-Stage Pipeline

47%

7 trials in Phase 3/4

Results Transparency

38%

5 of 13 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

Phase 4
4(36.4%)
Phase 2
3(27.3%)
Phase 3
3(27.3%)
Phase 1
1(9.1%)
11Total
Phase 4(4)
Phase 2(3)
Phase 3(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials
NCT06103760Phase 4Recruiting

Positioning of Esketamine Treatment in the Real-world Management of Depression

Role: collaborator

NCT01177059Phase 2Completed

Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial

Role: lead

NCT00074997Phase 2Completed

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

Role: lead

NCT01362426Completed

Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)

Role: lead

NCT01158924Phase 1Completed

A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration

Role: collaborator

NCT00562692Phase 3Terminated

Role of Natriuretic Peptides in the Treatment of Acutely Decompensated Heart Failure Patient With Obstructive Airways Disease

Role: collaborator

NCT00299676Completed

An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period

Role: lead

NCT00872521Phase 2Completed

A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma

Role: lead

NCT00464308Phase 4Completed

A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg

Role: lead

NCT01001481Completed

Schizophrenia Treatment Adherence Investigation (STAI)

Role: lead

NCT00297271Completed

Prospective Research in Memory Clinics (PRIME)

Role: lead

NCT00492661Phase 4Completed

A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus

Role: lead

NCT00473434Phase 3Completed

An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia

Role: lead

NCT00297310Phase 4Completed

Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation

Role: lead

NCT00249158Phase 3Completed

A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia

Role: lead

All 15 trials loaded